PL8177 Demonstrates Therapeutic Effects in Inflammatory Conditions
CRANBURY, N.J., Jan. 10, 2023. Palatin Technologies, Inc. a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced Frontiers in Immunology... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 10, 2023 Category: Pharmaceuticals Source Type: clinical trials

OM-85 in Paediatric Recurrent Respiratory Tract Infections With Wheezing Lower Respiratory Illness
Conditions:   Respiratory Tract Infections;   Wheezing Lower Respiratory Illness Interventions:   Drug: OM-85;   Drug: Placebo Sponsor:   OM Pharma Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2023 Category: Research Source Type: clinical trials